Lymphoma refers to a varied group of cancers of the blood that create from white blood cells in the lymphatic system. The lymphatic system is a group of organs and tissues that are component of the immune system and also help to type new blood cells.
It includes lymph nodes, small organs composed of lymphoid tissue situated at various points throughout the physique that are joined by lymphatic vessels; the spleen, a small organ on the left side of the abdomen that creates lymphocytes and shops red blood cells; the bone marrow, which produces new red and white blood cells; and the thymus gland just beneath the neck, which produces one type of lymphocyte, the T cell.
Two main types of lymphoma had been defined in the early 1980s- Hodgkin disease, occasionally known as Hodgkin lymphoma or HL; and non-Hodgkin lymphoma or NHL. HL was named for Thomas Hodgkin (1798-1866), a British physician who first described it in 1832, and was the first form of lymphoma to be officially defined, in 1963. Researchers focused on Hodgkin disease fairly early because it can be treated effectively by radiation therapy. Other types of lymphoma were then grouped under the common heading of non-Hodgkin lymphoma or NHL in 1982. This entry will focus on non-Hodgkin lymphoma or NHL.
Like Hodgkin illness, non-Hodgkin lymphoma begins in the lymphocytes, or white blood cells in the immune system. About 85 percent of NHLs originate in B cells, which are lymphocytes produced in the bone marrow. Most of the remaining 15 percent create from T cells produced in the thymus gland. What happens is that the abnormal B or T cells begin to multiply uncontrollably, often within the lymph nodes, causing swelling and pain. The lymphoma can spread from the lymph nodes towards the lymphatic vessels, tonsils, adenoids, spleen, thymus, and bone marrow. A non-Hodgkin lymphoma may also spread outside the lymphatic system to such other organs as the liver.
Non-Hodgkin lymphomas differ considerably in their speed of development and danger to survival. The 1982 classification categorized NHLs as low-grade, intermediate-grade, or highgrade depending on their aggressiveness and also the organs affected by the cancer. Low-grade lymphomas are occasionally called indolent lymphomas because they develop slowly and cause fairly few symptoms. Intermediate-grade and high-grade lymphomas develop and spread more rapidly and cause severe indicators and symptoms.
Non-Hodgkin lymphomas are brought on by the uncontrolled multiplication of abnormal B or T cells. What triggers the formation of the abnormal cells is not completely understood but is believed to be related to the activation of abnormal genes called oncogenes. Oncogenes are genes that have the possible to trigger normal cells into becoming cancerous. The most typical symptoms of NHLs are:
A couple of patients may have no symptoms in any way in the early stages of the disease other than swollen lymph nodes.
The diagnosis of NHLs can be complex because none of the indicators and symptoms of lymphomas are unique to this kind of cancer. The first step in diagnosing non-Hodgkin lymphoma is to rule out other diseases that can trigger swollen lymph nodes. In addition to examining the patient’s lymph nodes as component of a physical examination, the physician will order blood and urine tests to see regardless of whether an infection might be the cause of the patient’s signs and symptoms.
The physician will also ask how lengthy the signs and symptoms have been present; while the flu can trigger fever and fatigue, for instance, those symptoms should go away following a week or two. The subsequent step in diagnosis is imaging studies, including a chest x ray along with a computed tomography (CT) scan or magnetic resonance imaging (MRI) study of the chest, abdomen, or pelvic region.
These tests can identify the place and size of tumors within the lymph nodes in those components of the physique. A newer type of imaging test that may be ordered to detect lymphoma is really a positron emission tomography (PET) scan. In a PET scan, a radioactive substance called a tracer is injected into the patient’s circulation.
The radioactive material tends to concentrate in tissues that show an increased degree of metabolic activity, which frequently indicates a tumor. In addition to imaging studies, the physician will collect a tissue sample called a biopsy to be examined under the microscope in a specialized laboratory. If the swollen lymph node is close to the surface of the skin, the physician can eliminate the tissue sample via a hollow needle.
If the lymph node lies deeper within the physique, a surgeon may be called in to remove the tissue by making an incision. To determine regardless of whether the lymphoma has spread, the physician might also order a bone marrow biopsy. In this test, the patient is given a nearby anesthetic and a sample of bone marrow is removed from the hip bone through a hollow needle.
The first step in treating any kind of cancer is known as staging. Staging is really a description of the place of the cancer, its size, how far it has penetrated into healthy tissue, and regardless of whether it has spread to other components of the body. Non-Hodgkin’s lymphoma is classified into four stages:
If the patient has an indolent NHL without symptoms, the doctor might suggest watchful waiting instead of beginning treatment right away, as all forms of cancer therapy have some side effects. Early-stage NHLs are treated with either radiation therapy or a combination of radiation and chemotherapy. Chemotherapy for lymphoma usually involves a combination of drugs instead of a single agent. It might be given either intravenously or by mouth.
Early-stage lymphomas might also be treated with biological therapy, which involves vaccines along with other drugs intended to increase the functioning of the patient’s immune system. Biological therapy is also given to offset a few of the side effects of radiation and chemotherapy. Aggressive lymphomas are treated having a combination of chemotherapy and biological therapy.
Patients whose cancers return following therapy are given high doses of radiation, chemotherapy, or both, followed by stem cell transplantation. This process involves giving the patient stem cells following chemotherapy in order to help the patient’s bone marrow recover and begin to produce healthy blood cells again.
The prognosis of non-Hodgkin lymphoma depends on the specific tumor kind and location; the patient’s age; severity of signs and symptoms; the patient’s ability to tolerate intensive chemotherapy; and whether the disease has spread beyond the lymph nodes. In general, patients older than sixty, patients with weakened immune systems, and patients with T-cell lymphomas have worse prognoses than younger patients, patients who're otherwise healthy, and patients with B-cell lymphomas.
About 70 percent of patients with intermediate- or high-grade lymphomas at the time of diagnosis either fail to respond to treatment or have a recurrence of their cancer. About 5 percent of patients with recurrent cancer will survive for two years following the recurrence.
Our website is not responsible for the information contained by this article. Articleinput.com is a free articles resource thus practically any visitor can submit an article. However if you notice any copyrighted material, please contact us and we will remove the article(s) in discussion right away.
Note: This article was sent to us by: Shayne Douston at 01252011
1. Cancer: types and treatments that fight it
All articles are property of their respective authors. Please read our Privacy Policy!
© 2009 ArticleInput.com.
Partners: Damenmode